Imitrex

imitrexImitrex is used for the treatment of migraine headaches. Should you have any questions with respect to the information presented in this leaflet or need further clarifications about this medicine, contact your healthcare practitioner.

Mechanism

Imitrex targets blood vessels and nerves which are the cause migraine headaches.

Administration

The recommended dose of Imitrex is one a day. In case of severe headaches you may take up to two doses if so instructed by your doctor. A dose of 200 mg per day should not be exceeded.

Possible Side Effects

Dizziness, nausea, fatigue, drowsiness are among the possible side effects of Imitrex.

Warnings/Precautions

Imitrex should not be taken if you suffer from any of the following conditions: allergy to Imitrex, Raynaud syndrome, history of strokes, certain types of heart disease, transient ischemic attacks, varying blood pressure, peripheral vascular disease. If you smoke, have high cholesterole, high blood pressure or diabetes, consult your doctor before taking Imitrex.

Overdose

If you suspect an overdose, seek medical help immediately.

Drug Interactions

If you are using any headache medication, ergotamine or MAO inhibitors such as linezolid, furazolidone, tranylcypromine, phenelzine, selegiline, consult your doctor before using Imitrex.

Missing a Dose

Imitrex should not be administered on a regular basis. It should only be taken in case of migraine attacks.

Storage
Store Imitrex in its original container. Do not expose to heat or moisture. Store at normal temperature. Keep out of reach of children.

Pregnancy/Nursing

If you are pregnant or breast-feeding, consult your doctor before taking Imitrex.

More Information

Should you need more information, contact your doctor or healthcare provider.

Resources:
http://www.drugs.com/imitrex.html
http://www.rxlist.com/cgi/generic/sumitr.htm
http://www.drugdigest.org/DD/DVH/Uses/0,3915,633%7CImitrex,00.html

Related posts:

  1. Esgic Plus
Author: on December 4, 2009
Category: Headache
Tags: ,

Leave a Reply

*

Last articles